As a member of RAS GTPase-activating protein family (RAS-GAP), RAS protein activator like 2 (RASAL2) was first reported as a tumor suppressor and down-regulated in different types of tumors, e.g., luminal B breast cancer, lung cancer, and ovarian cancer 5-12. Here, RASAL2 is linked to neoplasm.